Melanoma central nervous system metastases: current approaches, challenges, and opportunities
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melanoma central nervous system metastases: current approaches, challenges, and opportunities
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 29, Issue 6, Pages 627-642
Publisher
Wiley
Online
2016-09-12
DOI
10.1111/pcmr.12538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pattern and outcome of disease progression in phase I study of vemurafenib in patients with metastatic melanoma (MM).
- (2017) K. B. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery
- (2016) Jack M. Qian et al. CANCER
- PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo
- (2016) H. Niessner et al. CLINICAL CANCER RESEARCH
- Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
- (2016) Sarah B Goldberg et al. LANCET ONCOLOGY
- Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel
- (2016) Ho Jeong Lee et al. NEURO-ONCOLOGY
- Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report
- (2015) Dae Won Kim et al. BMC CANCER
- A Quantitative System for Studying Metastasis Using Transparent Zebrafish
- (2015) S. Heilmann et al. CANCER RESEARCH
- A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis
- (2015) D. Hanniford et al. CLINICAL CANCER RESEARCH
- Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies
- (2015) C. Krepler et al. CLINICAL CANCER RESEARCH
- Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites
- (2015) H. M. Kluger et al. CLINICAL CANCER RESEARCH
- Complete Cytologic Remission of V600E BRAF-Mutant Melanoma–Associated Leptomeningeal Carcinomatosis Upon Treatment With Dabrafenib
- (2015) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery
- (2015) Andrew Yaeh et al. JOURNAL OF NEURO-ONCOLOGY
- Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab
- (2015) C. Frenard et al. JOURNAL OF NEURO-ONCOLOGY
- Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
- (2015) Georgina V Long et al. LANCET
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Response assessment criteria for brain metastases: proposal from the RANO group
- (2015) Nancy U Lin et al. LANCET ONCOLOGY
- Evolving treatment options for melanoma brain metastases
- (2015) Thankamma Ajithkumar et al. LANCET ONCOLOGY
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
- (2015) Lin Zhang et al. NATURE
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging strategies to effectively target autophagy in cancer
- (2015) V W Rebecca et al. ONCOGENE
- Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases
- (2015) Heike Seifert et al. Pigment Cell & Melanoma Research
- Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy
- (2015) Tomonori Kanda et al. RADIOLOGY
- Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging
- (2015) Robert J. McDonald et al. RADIOLOGY
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
- (2015) P. K. Brastianos et al. Cancer Discovery
- AKT1 Activation Promotes Development of Melanoma Metastases
- (2015) Joseph H. Cho et al. Cell Reports
- Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report
- (2015) I. C. Glitza et al. Cancer Immunology Research
- Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment
- (2015) J. V. Cohen et al. Cancer Immunology Research
- Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
- (2015) Berglind O. Einarsdottir et al. Oncotarget
- Astrocytes Upregulate Survival Genes in Tumor Cells and Induce Protection from Chemotherapy
- (2015) Sun-Jin Kim et al. NEOPLASIA
- Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
- (2014) A. M. Di Giacomo et al. ANNALS OF ONCOLOGY
- PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
- (2014) L. B. Jilaveanu et al. CLINICAL CANCER RESEARCH
- Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target
- (2014) G. Chen et al. CLINICAL CANCER RESEARCH
- Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations
- (2014) A. D. Bucheit et al. CLINICAL CANCER RESEARCH
- Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases
- (2014) Anna Sophie Berghoff et al. HISTOPATHOLOGY
- Intrathecal Interleukin-2 for Melanomatous Meningitis
- (2014) Nicole A. Shonka et al. JOURNAL OF CLINICAL ONCOLOGY
- Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
- (2014) Vinai Gondi et al. JOURNAL OF CLINICAL ONCOLOGY
- Response rate to vemurafenib in patients with B-RAF-positive melanoma brain metastases
- (2014) Marcin R. Dzienis et al. MELANOMA RESEARCH
- Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells
- (2014) Seung Wook Kim et al. NEURO-ONCOLOGY
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Humanization of Immunodeficient Mice Using Diagnostic Bone Marrow Aspirates from Carcinoma Patients
- (2014) Melanie Werner-Klein et al. PLoS One
- Patterns of response and progression in patients withBRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib
- (2013) Mary W. F . Azer et al. CANCER
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
- (2013) Rizwan Haq et al. CANCER CELL
- Automated Tracking of Nanoparticle-labeled Melanoma Cells Improves the Predictive Power of a Brain Metastasis Model
- (2013) T. Sundstrom et al. CANCER RESEARCH
- Advances in therapy for melanoma brain metastases
- (2013) Jaclyn C. Flanigan et al. CLINICS IN DERMATOLOGY
- Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
- (2013) Reinhard Dummer et al. EUROPEAN JOURNAL OF CANCER
- Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
- (2013) Nancy U Lin et al. LANCET ONCOLOGY
- Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
- (2013) Nancy U Lin et al. LANCET ONCOLOGY
- Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
- (2013) Maya Mathew et al. MELANOMA RESEARCH
- PTEN functions as a melanoma tumor suppressor by promoting host immune response
- (2013) Y Dong et al. ONCOGENE
- Development and characterization of a clinically relevant mouse model of melanoma brain metastasis
- (2013) Amr Morsi et al. Pigment Cell & Melanoma Research
- Rettransgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells
- (2013) Viktor Umansky et al. Pigment Cell & Melanoma Research
- High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material
- (2013) Tomonori Kanda et al. RADIOLOGY
- Psychometric validation of the functional assessment of cancer therapy—brain (FACT-Br) for assessing quality of life in patients with brain metastases
- (2013) Nemica Thavarajah et al. SUPPORTIVE CARE IN CANCER
- Vemurafenib and Radiosensitization
- (2013) Lise Boussemart et al. JAMA Dermatology
- In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain Metastasis
- (2013) Avital Gaziel-Sovran et al. Frontiers in Oncology
- Human melanoma cells in the rhombencephalon of the chick embryo: a novel model for brain metastasis
- (2012) Christian Busch et al. EXPERIMENTAL DERMATOLOGY
- BRAF/NRASMutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
- (2012) Maria Colombino et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors
- (2012) Pedro Pérez Segura et al. JOURNAL OF NEURO-ONCOLOGY
- Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
- (2012) Jonathan P. S. Knisely et al. JOURNAL OF NEUROSURGERY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
- (2012) Anna Maria Di Giacomo et al. LANCET ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
- (2012) Heike Niessner et al. Cancer Medicine
- Leptomeningeal melanomatosis: Stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine
- (2011) Niklas Schaefer et al. ACTA ONCOLOGICA
- Emerging insights into the molecular biology of brain metastases
- (2011) Guo Chen et al. BIOCHEMICAL PHARMACOLOGY
- Antitumor Activity of NVP-BKM120--A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
- (2011) D. Koul et al. CLINICAL CANCER RESEARCH
- B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
- (2011) Christina Tekle et al. INTERNATIONAL JOURNAL OF CANCER
- The metastatic microenvironment: Brain-residing melanoma metastasis and dormant micrometastasis
- (2011) Sivan Izraely et al. INTERNATIONAL JOURNAL OF CANCER
- Safety and clinical activity of ipilimumab in melanoma patients with brain metastases
- (2011) Jeffrey S. Weber et al. MELANOMA RESEARCH
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis
- (2011) E. S. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI3K and STAT3: A New Alliance
- (2011) P. K. Vogt et al. Cancer Discovery
- Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma
- (2011) Andrea J. McKinney et al. Chinese Journal of Cancer
- Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis
- (2010) Anthony J Perissinotti et al. ANNALS OF PHARMACOTHERAPY
- Prognostic factors for survival in melanoma patients with brain metastases
- (2010) Michael A. Davies et al. CANCER
- Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
- (2010) J. J. Hong et al. CLINICAL CANCER RESEARCH
- Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis
- (2010) Karin Oechsle et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Leptomeningeal Disease
- (2010) Morris D. Groves NEUROSURGERY CLINICS OF NORTH AMERICA
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response Assessment in Neuro-Oncology
- (2010) Eudocia C. Quant et al. Current Oncology Reports
- Comparison of the Added Value of Contrast-Enhanced 3D Fluid-Attenuated Inversion Recovery and Magnetization-Prepared Rapid Acquisition of Gradient Echo Sequences in Relation to Conventional Postcontrast T1-Weighted Images for the Evaluation of Leptomeningeal Diseases at 3T
- (2009) H. Fukuoka et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Brain Metastasis: Opportunities in Basic and Translational Research
- (2009) E. A. Maher et al. CANCER RESEARCH
- Transforming Growth Factor- 2 Is a Molecular Determinant for Site-Specific Melanoma Metastasis in the Brain
- (2009) C. Zhang et al. CANCER RESEARCH
- Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
- (2009) M. A. Davies et al. CLINICAL CANCER RESEARCH
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
- (2009) J. Weber et al. CLINICAL CANCER RESEARCH
- Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 Cases
- (2009) Javier Perez-Rodriguez et al. RADIOLOGY
- Development of a Preclinical Model of Spontaneous Human Melanoma Central Nervous System Metastasis
- (2008) W. Cruz-Munoz et al. CANCER RESEARCH
- Molecular Basis for the Critical Role of Suppressor of Cytokine Signaling-1 in Melanoma Brain Metastasis
- (2008) F.-J. Huang et al. CANCER RESEARCH
- Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features
- (2008) Jeffrey J. Raizer et al. NEURO-ONCOLOGY
- Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers
- (2008) Martin R. Prince et al. RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started